A novel homozygous variant in ZFP36L2 cause female infertility due to oocyte maturation defect

Clin Genet. 2023 Oct;104(4):461-465. doi: 10.1111/cge.14362. Epub 2023 May 21.

Abstract

Normal oocyte maturation is an important requirement for the success of human reproduction, and defects in this process will lead to female infertility and repeated IVF/ICSI failures. In order to identify genetic factors that are responsible for oocyte maturation defect, we used whole exome sequencing in the affected individual with oocyte maturation defect from a consanguineous family and identified a homozygous variant c.853_861del (p.285_287del) in ZFP36L2. ZFP36L2 is a RNA-binding protein, which regulates maternal mRNA decay and oocyte maturation. In vitro studies showed that the variant caused decreased protein levels of ZFP36L2 in oocytes due to mRNA instability and might lead to the loss of its function to degrade maternal mRNAs. Previous study showed that the pathogenic variants in ZFP36L2 were associated with early embryonic arrest. In contrast, we identified a novel ZFP36L2 variant in the affected individual with oocyte maturation defect, which further broadened the mutational and phenotypic spectrum of ZFP36L2, suggesting that ZFP36L2 might be a genetic diagnostic marker for the affected individuals with oocyte maturation defect.

Keywords: ZFP36L2; female infertility; oocyte maturation defect; variant.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • Homozygote
  • Humans
  • Infertility, Female* / genetics
  • Infertility, Female* / pathology
  • Mutation
  • Oocytes / metabolism
  • Oogenesis / genetics
  • Transcription Factors / genetics

Substances

  • ZFP36L2 protein, human
  • Transcription Factors